造血细胞移植后潜伏性结核病再激活的风险。
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation.
机构信息
Division of Infectious Diseases, Brigham and Women's Hospital.
Department of Medical Oncology, Dana-Farber Cancer Institute.
出版信息
Clin Infect Dis. 2019 Aug 16;69(5):869-872. doi: 10.1093/cid/ciz048.
Abstract
There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).
摘要
在 2010 年至 2015 年期间，对 2531 名接受造血细胞移植的患者进行了长达 7323 人年的随访，结果在 95%的置信区间（CI）中，0.0-0.05 例/100 人年），包括 29 例未经治疗的潜伏性结核患者（95%CI，0.0-4.06 例/100 人年）。
相似文献
1
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation.造血细胞移植后潜伏性结核病再激活的风险。
Clin Infect Dis. 2019 Aug 16;69(5):869-872. doi: 10.1093/cid/ciz048.
2
Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.比较结核菌素皮肤试验和干扰素-γ释放试验在造血干细胞移植中潜伏性结核分枝杆菌感染的患病率。
Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):899-902. doi: 10.1007/s10096-023-04613-w. Epub 2023 May 1.
3
Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.评估干扰素-γ释放试验和结核菌素皮肤试验在检测韩国风湿性疾病患者（生物制剂候选者）潜伏性结核分枝杆菌感染中的实用性。
Int J Rheum Dis. 2015 Mar;18(3):315-22. doi: 10.1111/1756-185X.12515. Epub 2014 Oct 28.
4
Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.接受生物治疗的炎症性肠病患者潜伏性结核感染治疗的结果。
Inflamm Bowel Dis. 2018 Sep 15;24(10):2272-2277. doi: 10.1093/ibd/izy133.
5
The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: A retrospective cohort study from a center in Turkey.造血干细胞移植受者中结核感染的发生率：来自土耳其一个中心的回顾性队列研究。
Transpl Infect Dis. 2018 Aug;20(4):e12912. doi: 10.1111/tid.12912. Epub 2018 May 9.
6
Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.实体器官移植后潜伏性结核感染的治疗与结核病风险：综述
Transpl Infect Dis. 2019 Dec;21(6):e13178. doi: 10.1111/tid.13178. Epub 2019 Oct 1.
7
Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City.在纽约市接触传染性肺结核病例的队列中，主动发现和预防结核病。
Clin Infect Dis. 2012 May;54(9):1287-95. doi: 10.1093/cid/cis029. Epub 2012 Mar 12.
8
Tuberculosis reactivation in referrals to public health clinics in Texas.德克萨斯州公共卫生诊所转诊的结核病再激活。
Am J Med Sci. 2013 Dec;346(6):442-6. doi: 10.1097/MAJ.0b013e318285f7db.
9
Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.在造血干细胞移植前，用全血干扰素-γ释放试验（QuantiFERON-TB Gold In-Tube test）与结核菌素皮肤试验检测潜伏性结核感染的比较。
Transpl Infect Dis. 2013 Feb;15(1):104-9. doi: 10.1111/j.1399-3062.2012.00765.x. Epub 2012 Jul 23.
10
Detection and management of latent tuberculosis in liver transplant patients.肝移植患者潜伏性结核的检测和管理。
Liver Transpl. 2011 Mar;17(3):306-14. doi: 10.1002/lt.22203.
引用本文的文献
1
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.新诊断急性白血病成年患者潜伏性结核感染（LTBI）的管理：对意大利SEIFEM（血液系统疾病感染流行病学监测）组织所属各中心的一项调查结果
Ann Hematol. 2024 Dec;103(12):6045-6050. doi: 10.1007/s00277-024-06047-6. Epub 2024 Oct 28.
2
Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence Country.意大利的急性白血病与潜伏性结核感染：在结核病低发病率国家进行的结核感染T细胞检测筛查
Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024054. doi: 10.4084/MJHID.2024.054. eCollection 2024.
3
Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.比较结核菌素皮肤试验和干扰素-γ释放试验在造血干细胞移植中潜伏性结核分枝杆菌感染的患病率。
Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):899-902. doi: 10.1007/s10096-023-04613-w. Epub 2023 May 1.
4
Management of Latent Tuberculosis Infection Based on T-SPOT.TB Assay in Patients with Hematological Malignancies.基于T-SPOT.TB检测的血液系统恶性肿瘤患者潜伏性结核感染的管理
Mediterr J Hematol Infect Dis. 2023 Jan 1;15(1):e2023003. doi: 10.4084/MJHID.2023.003. eCollection 2023.
5
Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature.造血干细胞移植患者移植后早期出现非典型皮肤表现的播散性肺结核：病例报告及文献复习
Open Forum Infect Dis. 2022 Nov 29;9(12):ofac643. doi: 10.1093/ofid/ofac643. eCollection 2022 Dec.
6
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome.罗马 Tor Vergata 大学医院的一项回顾性意大利队列研究：造血干细胞移植受者中的潜伏性结核病感染。
Int J Environ Res Public Health. 2022 Aug 27;19(17):10693. doi: 10.3390/ijerph191710693.
7
Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature.异基因造血干细胞移植儿童受者中结核病的识别与治疗：病例系列及文献综述
Infect Drug Resist. 2020 Jul 31;13:2641-2648. doi: 10.2147/IDR.S256298. eCollection 2020.
8
A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients.造血细胞移植受者中潜伏性结核感染的靶向筛查计划。
Open Forum Infect Dis. 2020 Jun 10;7(7):ofaa224. doi: 10.1093/ofid/ofaa224. eCollection 2020 Jul.
9
Disseminated Tuberculosis with Cholecystitis in a Patient after Cord Blood Transplantation. 脐带血移植后并发播散性肺结核合并胆囊炎。
Intern Med. 2020 Nov 1;59(21):2769-2771. doi: 10.2169/internalmedicine.4923-20. Epub 2020 Jul 14.
10
Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014.2006-2014 年综合性癌症中心的活动性结核分枝杆菌感染。
BMC Infect Dis. 2019 Nov 6;19(1):934. doi: 10.1186/s12879-019-4586-y.
本文引用的文献
1
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.γ-干扰素释放试验和结核菌素皮肤试验对预测活动性结核病发生的预后价值（英国预测结核）：一项前瞻性队列研究。
Lancet Infect Dis. 2018 Oct;18(10):1077-1087. doi: 10.1016/S1473-3099(18)30355-4. Epub 2018 Aug 30.
2
Revisiting the timetable of tuberculosis.重新审视结核病的时间表。
BMJ. 2018 Aug 23;362:k2738. doi: 10.1136/bmj.k2738.
3
Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic area.异基因造血干细胞移植受者的分枝杆菌感染：高发地区的队列研究。
J Microbiol Immunol Infect. 2020 Apr;53(2):274-282. doi: 10.1016/j.jmii.2018.07.001. Epub 2018 Jul 26.
4
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.成人潜伏性结核：利福平治疗 4 个月或异烟肼治疗 9 个月。
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
5
Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation.异基因造血干细胞移植后结核病的发病率及临床特征
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12794. Epub 2017 Nov 26.
6
Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis.癌症患者活动性肺结核的风险：一项系统评价和荟萃分析。
Clin Infect Dis. 2017 Mar 1;64(5):635-644. doi: 10.1093/cid/ciw838. Epub 2016 Dec 16.
7
Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.造血干细胞移植受者患结核病的长期风险：一项为期10年的全国性研究。
Int J Tuberc Lung Dis. 2015 Jan;19(1):58-64. doi: 10.5588/ijtld.14.0301.
8
Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.糖尿病会增加活动性肺结核的风险：对13项观察性研究的系统评价
PLoS Med. 2008 Jul 15;5(7):e152. doi: 10.1371/journal.pmed.0050152.
9
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States.美国胸科学会/疾病控制与预防中心/美国传染病学会：美国结核病控制
Am J Respir Crit Care Med. 2005 Nov 1;172(9):1169-227. doi: 10.1164/rccm.2508001.
10
Tuberculosis morbidity in the U.S. Navy: its distribution and decline.美国海军中的结核病发病率：其分布与下降情况
Am Rev Respir Dis. 1974 Nov;110(5):572-80. doi: 10.1164/arrd.1974.110.5.572.
Zotero 插件